Results 141 to 150 of about 2,707 (196)

Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer. [PDF]

Virchows Arch
Martini C, Logan JM, Sorvina A, Prabhakaran S, Ung BSY, Johnson IRD, Hickey SM, Brooks RD, kConFab Consortium, Caruso MC, Klebe S, Karageorgos L, O'Leary JJ, Delahunt B, Samaratunga H, Brooks DA.   +15 more
europepmc   +1 more source

Neuroendocrine neoplasms as a lynch syndrome manifestation: a case report and comprehensive literature review. [PDF]

Front Endocrinol (Lausanne)
Bernal Zárate MP, Mendivelso-Gonzalez DF, Torres WC, González Clavijo AM, Ballen DF, Parra Medina R, Riaño-Moreno JC.   +6 more
europepmc   +1 more source

PSA 2010 - Aufbruch in eine neue Ära der Früherkennung des Prostatakarzinom [PDF]

, 2006
Börgermann, Christof, Fornara, Paolo, Graefen, Markus, Hammerer, Peter, Rübben, Herbert, Schröder, Fritz H., Semjonow, Axel, Sieverding, Monika   +7 more
core   +1 more source

Circulating microRNAs in prostate cancer - Non-invasive biomarkers for diagnosis, prognosis and therapy: A review. [PDF]

Biomol Biomed
Volar E, Vuković B, Franin I, Madunić Z, Bijelić A, Čelap I, Sinčić N, Tomašković I, Murgić J, Ulamec M.   +9 more
europepmc   +1 more source

Clinical feasibility of MRI-guided in-bore prostate biopsies at 0.55T. [PDF]

Abdom Radiol (NY)
Kaur T, Jiang Y, Seiberlich N, Hussain H, Wells S, Wei J, Caoili E, Gulani V.   +7 more
europepmc   +1 more source

PGC1α as a downstream effector of KDM5B promotes the progression of androgen receptor-positive and androgen receptor-negative prostate cancers. [PDF]

Am J Cancer Res
Teramoto Y, Yang Z, Matsukawa T, Najafi MAE, Goto T, Miyamoto H.   +5 more
europepmc   +1 more source

Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology. [PDF]

Sci Rep
Eminaga O, Abbas M, Kunder C, Tolkach Y, Han R, Brooks JD, Nolley R, Semjonow A, Boegemann M, West R, Long J, Fan RE, Bettendorf O.   +12 more
europepmc   +1 more source

Decoding GDF15: Impact on prostate cancer metabolism, chemoresistance, and clinical applications. [PDF]

Chin Med J (Engl)
Zhu W, Xu H, Xiong X, Li Y, Feng D, Huang W, Wei Q, Yang L.   +7 more
europepmc   +1 more source

DMRIntTk: Integrating different DMR sets based on density peak clustering. [PDF]

PLoS One
Zhang W, Jie W, Cui W, Duan G, Zou Y, Peng X.   +5 more
europepmc   +1 more source